KFC
IRWD icon

Klingenstein Fields & Co’s Ironwood Pharmaceuticals IRWD Stock Holding History

Klingenstein Fields & Co’s Portfolio IRWD Stock Details IRWD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-28,213
Closed -$235K – 317
2013
Q2 		$235K Buy
+28,213
New +$342K 0.01% 285

Other funds holding IRWD

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $43.7B AUM 27.76% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Klingenstein Fields & Co's IRWD Position: Q3 2013 in Review

Klingenstein Fields & Co sold out of Ironwood Pharmaceuticals (IRWD) in Q3 2013, closing a stake of 28,213 shares — an estimated $235K sold.

Klingenstein Fields & Co first reported a position in IRWD in Q2 2013 and held it in 1 quarter. The position peaked at $235K in Q2 2013. 124 funds tracked by Wall St. Rank hold IRWD as of Q3 2013.

  • Klingenstein Fields & Co reported no remaining Ironwood Pharmaceuticals position as of Q3 2013 after selling out during the quarter.
  • Klingenstein Fields & Co sold 28,213 Ironwood Pharmaceuticals shares in Q3 2013, an estimated $235K.
  • Klingenstein Fields & Co first reported a position in Ironwood Pharmaceuticals in Q2 2013 and held it in 1 quarter.
  • Klingenstein Fields & Co's Ironwood Pharmaceuticals position peaked at $235K in Q2 2013.
  • 124 funds tracked by Wall St. Rank held Ironwood Pharmaceuticals as of Q3 2013.

Based on Klingenstein Fields & Co's 13F filing for Q3 2013, filed 4 Nov 2013.